February 12, 2026
An innovation to detect heart rate, respiration and oxygen saturation. A method to fabricate vertically aligned nanocomposites. A portable method to detect and quantify Delta 9 THC. A protein-based adhesive.
Excellence at scale: Purdue ranks seventh nationally for U.S. patents received
February 11, 2026
Researchers have developed a groundbreaking new single-ion detector capable of identifying any ion type without requiring specific molecular tailoring. Namita Narendra and Tillmann Kubis, both from Purdue University, detail a carbon nanotube-based device that achieves this feat by temporarily altering the transistor’s operating principle to create a resonant tunneling diode when an ion is present. This innovation represents a significant advance in ion sensing, demonstrated by a five-orders-of-magnitude increase in current induced by just one ion, and promises continuous, real-time monitoring with broad applicability across diverse fields like environmental monitoring and biomedical diagnostics.
February 9, 2026
Improved Pharma is pleased to announce the expansion of its solid-state characterization services, offering expert interpretation and state-of-the-art data acquisition. This service is designed to address the growing industry need for more accurate interpretation and defensible data that can withstand the rigors of regulatory reviews and the scrutiny of patent examiners.
February 9, 2026
A new smart platform invented by Purdue University researchers to wirelessly monitor subsoil health could change the landscape of agricultural sensing systems.
February 6, 2026
The binding of the sperm protein IZUMO1 to the oocyte receptor JUNO is an essential step in fertilization. Genetic deletion of IZUMO1 results in sterility, making this sperm protein a potential target for the development of an immunocontraceptive vaccine for the control of wildlife populations. However, contradictory results of the effect of immunization with IZUMO1 or IZUMO1-derived peptides have been reported. In this study, the effect of immunization with a recombinant mouse IZUMO1 peptide comprised of the extracellular Izumo, hairpin and Ig-like domains of IZUMO1 with different adjuvants was investigated in mice.
Role of adjuvants in the efficacy of an IZUMO1-based immunocontraceptive vaccine in mice
February 6, 2026
The Purdue University Board of Trustees on Friday (Feb. 6) ratified faculty and dean appointments and approved a new degree and resolutions of appreciation and namings.
Trustees ratify faculty, dean positions; approve new degree, resolutions of appreciation and namings
February 6, 2026
Nine Purdue University Department of Nutrition Science researchers and other colleagues collaborated on a report finding people respond very differently to the same foods, which is why “precision nutrition” — tailoring dietary advice to individuals — is gaining attention. In this review, the researchers studied how behaviors are shaped by a complex mix of biology and lived experience — including influences of age, sex, body size, genetics, culture, appetite, taste, smell, gut–brain signals and the microbiome.
February 6, 2026
Mycoponic biotechnology, inspired by hydroponics—a vital technology for agriculture research and space exploration, is limited by innate substrate contamination commonplace in commercial mycoproduction. Using micro-structured ceramic tubes as “substrate,” mycoponics provides mycelial cellular filaments with an air-phase/solid-state, antimicrobial interface for cellular liquid nutrient media uptake.
Mycoponics: Controlled Bioproduction Utilizing Biophysical, Solid-State, Liquid Nutrient Delivery
February 2, 2026
The Biomolecular Design Seed Grant awards research projects that accelerate collaborative research in the molecular biosciences at Purdue University. In the first year of this grant, two research projects have been selected. The projects are “AI-guided design of compact CRISPR-associated transposons for programmable gene insertion” submitted by Leifu Chang, Daisuke Kihara, and Ruqi Zhang and "A structured-conditioned, Small-Molecule-Driven Framework for Protein Design” submitted by Ramaswamy Subramanian and Ananth Grama.
Two research projects selected for Biomolecular Design Seed Grant
February 2, 2026
Cell viability assays (CVAs) are widely used in cell biology, biomedical research, drug development, and biotechnology to assess cell health, proliferation, cytotoxicity, and functional activity under various conditions. Key applications span from everyday cell culture monitoring to drug screening and toxicology studies, immunology, vaccine development, and stem cell and regenerative medicine.
